Pediatrix Medical Group, Inc.
MD NYSE· Services-Hospitals
Last close · Oct 27, 2026
$28.84
KIRA · Stoqly’s AI analyst, in plain words
- Pediatrix Medical Group, Inc. had $1.9B of revenue in fiscal 2025, down 4.9% on the year before. Over five years, revenue changed +2.0% a year on average.
- Its operating margin was 10.9%, up 14.3 pts: of every 100 in sales, about 11 is left after running the business.
- Pediatrix Medical Group, Inc. made $165M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew −6.3% a year.
- Pediatrix Medical Group, Inc. returned $86.7M to shareholders in fiscal 2025. The diluted share count rose 2.5%.
- Pediatrix Medical Group, Inc. owes $101M more than it holds in cash, about 0.4 years of operating profit.
Market cap
$2.3B
P/E
13.8x
Revenue
$1.9B
Net income
$165M
Free cash flow
—
Operating margin
10.9%
Pediatrix Medical Group, Inc. in 30 seconds · fiscal 2025
Are sales growing?
−4.9%
No. Sales fell 4.9% last year.
Does it make a profit?
8.6%
A little. It keeps 8.6% of every sale as profit.
Is debt under control?
0.4x
Yes. It could repay its debt with 0.4 years of operating profit.
How healthy are the accounts?
6 / 8
Mixed. It passes 6 of 8 health tests.
How is the share priced?
13.8x
One share costs 13.8 times its yearly profit per share.
What Pediatrix Medical Group, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 19, 2026
- Legal name
- Pediatrix Medical Group, Inc.
- CIK
- 0000893949
Pediatrix Medical Group, Inc. · MD
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $1.9B | $2.0B | $2.0B | $2.0B | $1.9B |
| Revenue growth | 10.2% | 3.2% | 1.1% | 0.9% | −4.9% |
| Operating margin | 10.6% | 8.8% | 0.4% | −3.4% | 10.9% |
| Net income | $131M | $66.3M | −$60.4M | −$99.1M | $165M |
| Net margin | 6.9% | 3.4% | −3.0% | −4.9% | 8.6% |
| Diluted EPS | $1.53 | $0.79 | −$0.73 | −$1.19 | $1.94 |
| Cash | |||||
| Cash from operations | $76.7M | $167M | $137M | $207M | $271M |
| Share buybacks | $4.7M | $88.5M | $0.9M | $1.7M | $86.7M |
| Share count change | 2.9% | −2.0% | −2.3% | 1.4% | 2.5% |
| Debt and strength | |||||
| Cash and short-term investments | $487M | $103M | $178M | $349M | $500M |
| Debt incl. finance leases | $1.0B | $648M | $631M | $617M | $601M |
| Shareholders' equity | $896M | $892M | $849M | $765M | $866M |
| Net debt / EBITDA | 2.2x | 2.6x | 10.4x | — | 0.4x |
| Current ratio | 2.0x | 1.0x | 1.2x | 1.5x | 1.7x |
| Interest coverage | 3.0x | 4.4x | 0.2x | −1.7x | 5.8x |
| Returns and quality | |||||
| Return on capital | 11.6% | 9.3% | 0.4% | −5.3% | 16.6% |
| Return on equity | 15.9% | 7.4% | −6.9% | −12.3% | 20.3% |
| Piotroski F-score | 5 | 6 | 5 | 4 | 6 |
| Altman Z'' | 1.8 | 1.0 | 0.7 | 0.6 | 2.1 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$1.8M
4 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Pediatrix Medical Group, Inc. · MD
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $28.84 a share, the company is worth $2.3B: 13.8 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0000893949). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.